Cases & Deals

BioMarin asserts patent infringement claims against Dr. Reddy's Laboratories related to Kuvan®

Clients BioMarin Pharmaceutical Inc.

Jones Day represented BioMarin Pharmaceutical, Inc. in a patent infringement action against Dr. Reddy's Laboratories relating to the defendant's submission of an Abbreviated New Drug Application to the FDA seeking approval of a generic versions of Kuvan® (sapropterin dihydrocholride), the only FDA-approved treatment to reduce blood phenylalanine levels in persons with BH-4 responsive phenylketonuria (PKU). A settlement was reaches and the case dismissed.

BioMarin Pharmaceutical Inc. et al. v. Dr. Reddy's Laboratories, Inc. et al., Case No. 3:14-cv-07203 (D.N.J.)

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.